Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain

NCT00101621 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Pain

Interventions

DRUG: M40403

Sponsor

MetaPhore Pharmaceuticals